Gene responsible for common hearing loss identified for first timeJune 18, 2007A gene responsible for the single most common cause of hearing loss among white adults, otosclerosis, has been identified for the first time, a scientist told the annual conference of the European Society of Human Genetics in Nice, France. Ms Melissa Thys, from the Department of Medical Genetics, University of Antwerp, Belgium, said that this finding may be a step towards new treatments for otosclerosis, which affects approximately 1 in 250 people. Otosclerosis is a multifactorial disease, caused by an interaction of genetic and environmental factors. The outcome is a progressive hearing loss as the growing bone in the middle ear interrupts the sound waves passing to the inner ear. While the causative factors remain unknown, now one of the genetic components has been identified, Ms Thys told the conference. "The gene in which the variant is located points to a pathway that contributes to the disease. This may be a lead for better forms of treatment in the future; currently the best option is an operation. However, there is often an additional component of hearing loss which can't be restored by surgery. As the gene involved is a growth factor, and the disease manifests itself by the abnormal growth of bone in the middle ear, it may have a large potential for therapy", she said. Improved understanding may also lead to prevention strategies. Ms Thys and her team decided to study a gene called TGBF1 which they already knew had non-genetic indications of involvement in otosclerosis: it plays a role during embryonic development of the ear and is expressed in otosclerotic bone. They used SNP (single nucleotide polymorphism) analysis, or looking at DNA sequence variations occurring in a single nucleotide, A, T, C or G, to study a large patient and control population from Belgium and The Netherlands. They found significant results for an amino acid changing SNP inTGBF1, and that this remained significant after correcting for multiple testing. Analysis of a large French group showed the same association. "Combining the data from both groups with a common odds ratio gave a very significant result, from which we were able to conclude that we were the first to identify a gene that influences the susceptibility for otosclerosis", said Ms Thys. "And, as further evidence, we were also able to show that a more active variant of this gene is protective against the disease." European Society of Human Genetics |
|||||||||||||||||||||
| Related Hearing Loss Current Events and Hearing Loss News Articles 'Escaped' proteins add to hearing loss in elderly, UF researchers find Age-related hearing loss is the most common sensory disorder among the elderly. But scientists are still trying to figure out what cellular processes govern or contribute to the loss. Squeak, squeak -- can you hear me now? What do you get when you cross a mouse with poor hearing and a mouse with even worse hearing? Ironically, a new strain of mice with "golden ears" - mice that have outstanding hearing as they age. Global death toll: 1 million premature babies every year More than one million infants die each year because they are born too early, according to the just released White Paper, The Global and Regional Toll of Preterm Birth. Scripps research scientists identify genetic cause for type of deafness A team led by scientists from The Scripps Research Institute has discovered a genetic cause of progressive hearing loss. Researchers report gene associated with language, speech and reading disorders A new candidate gene for Specific Language Impairment has been identified by a research team directed by Mabel Rice at the University of Kansas, in collaboration with Shelley Smith, University of Nebraska Medical Center, and Javier Gayán of Neocodex, Seville, Spain. Taking up music so you can hear Anyone with an MP3 device -- just about every man, woman and child on the planet today, it seems -- has a notion of the majesty of music, of the primal place it holds in the human imagination. Anti-angiogenesis treatment improves hearing in some NF2 patients Treatment with the angiogenesis inhibitor bevacizumab improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 (NF2). Common antibacterial treatment linked to sensorineural hearing loss in cystic fibrosis patients An otherwise effective treatment for cystic fibrosis places patients at a high risk of sensorineural hearing loss, according to new research published in the July edition of Otolaryngology-Head and Neck Surgery. Singapore nanotechnology combats fatal brain infections Doctors may get a new arsenal for meningitis treatment and the war on drug-resistant bacteria and fungal infections with novel peptide nanoparticles developed by scientists at the Institute of Bioengineering and Nanotechnology (IBN) of Singapore and reported in Nature Nanotechnology. Got ear plugs? You may want to sport them on the subway and other mass transit, researchers say The U.S. mass transit system, the largest in the world, provides affordable and efficient transportation to more than 33 million riders each weekday. The system is generally considered one of the safest modes of travel. But recent public health studies have identified several sources of environmental hazards associated with mass transit, including excessive noise, a large and growing problem in urban settings. More Hearing Loss Current Events and Hearing Loss News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||